How Much Did Acurable Raise?
Funding & Key Investors

Acurable, a company specializing in wearable medical devices for home patient use, has secured $11M in total capital. The company recently announced a $11M major strategic investment, underscoring its progress in the health technology sector. This latest financing round follows previous funding efforts, indicating a strong investor appetite for Acurable's innovative solutions.

What is Acurable?

Acurable
ManufacturingMedical Devices & EquipmentBusiness Services

Acurable is at the forefront of developing user-friendly wearable medical devices for at-home patient monitoring. Their product portfolio includes the AcuPebble SA100, the first medical device to achieve CE marking for automated Obstructive Sleep Apnoea diagnosis, and the AcuPebble RE100 for continuous breathing and cardiac biosignal research. These innovations are built upon patented technology, cultivated over a decade at Imperial College London, focusing on non-invasive physiological monitoring and advanced signal processing. The company's commitment to advancing healthcare through technology has been recognized with accolades such as an XPrize and an IET Innovations Award.

How much funding has Acurable raised?

Acurable has raised a total of $11M across 1 funding round:

2022

Series A

$11M

Series A (2022): $11M with participation from Comprador Holdings, Mundi Ventures, Kibo Ventures, and Kindred Capital

Key Investors in Acurable

Mundi Ventures

Mundi Ventures is an investment firm that supports bold and purpose-driven founders in various sectors including deep tech, insurtech, fintech, and climate tech. They focus on backing innovative entrepreneurs who are building solutions for significant challenges.

Kindred Capital

Kindred Capital is a venture capital firm founded in 2015 and headquartered in London, England, United Kingdom. It offers equitable venture and investment thesis.

Comprador Holdings

Undisclosed investor participating in the funding round.

What's next for Acurable?

With its recent major strategic investment, Acurable is poised for significant expansion and further product development. The enterprise-level funding suggests a move towards scaling operations, potentially broadening market reach for its diagnostic and monitoring devices. This capital infusion will likely accelerate research into new physiological monitoring technologies and enhance the capabilities of their existing product lines. Acurable's strategic backing indicates a strong belief in its mission to improve patient care through accessible, accurate home-use medical technology.

See full Acurable company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Industrial Machinery & EquipmentManufacturing
Industrial Machinery & EquipmentManufacturing
Cosmetics, Beauty Supply & Personal Care ProductsManufacturingRetailFlowers, Gifts & Specialty Stores
ManufacturingTest & Measurement EquipmentConsumer ServicesRepair Services

Frequently Asked Questions Regarding Acurable Financial Insights

What are the most recent funding rounds that Acurable has completed, and what were the funding rounds?
Acurable has recently completed 1 funding rounds: Series A on Oct 2, 2022.
What is the total amount of funding Acurable has raised to date?
Acurable has raised a total of $11M in funding to date.
How many funding rounds has Acurable completed?
Acurable has completed 1 funding rounds.
How much funding did Acurable raise in its most recent funding round?
Acurable raised $11M in its most recent funding round.
Who are the lead investors in Acurable's latest funding round?
The lead investor in Acurable's latest funding round was Comprador Holdings. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Acurable's history?
The largest funding round in Acurable's history was $11M.
See more information about Acurable